| abstract |
The invention concerns compounds of formula (I) and their solvates and/or hydrates, having affinity and selectivity for V1b or for both V1b and V1a arginine-vasopressin receptors. The invention also concerns a method for preparing them, intermediate compounds of formula (II) useful for preparing them, pharmaceutical compositions containing them, and their use for preparing medicines. |